Table 1 EpCAM and Trop2 overexpression in relation to clinicopathologic factors in adenocarcinoma

Sex

Male

52

26 (50.0)

0.019

13 (25.0)

0.621

Female

48

13 (27.1)

10 (20.8)

Age at diagnosis

100

0.490

0.102

Histologic grade

Well differentiated

42

7 (16.7)

0.000

5 (11.9)

0.015

Moderately differentiated

38

15 (39.5)

9 (23.7)

Poorly differentiated

20

17 (85.0)

9 (45.0)

T stage

pT1

68

21 (30.9)

0.015

21 (24.7)

0.335

pT2, 3, 4

32

18 (56.3)

2 (13.3)

N stage

pN0

80

27 (33.8)

0.031

17 (21.3)

0.406

pN1, 2, 3

20

12 (60.0)

6 (30.0)

TNM stage

I

68

21 (30.9)

0.050

15 (22.1)

0.70

II, III

32

18 (56.3)

8 (25.0)

Smoking

81

Never

39

11 (28.2)

0.085

7 (17.9)

0.947

Quit

19

7 (36.8)

4 (21.1)

Current

23

13 (56.5)

4 (17.4)

Smoking (PY)

79

0.376

0.441